Covalon Technologies (COV) Set to Announce Quarterly Earnings on Wednesday

Covalon Technologies (CVE:COV) is scheduled to be issuing its quarterly earnings data before the market opens on Wednesday, August 21st.

Covalon Technologies (CVE:COV) last posted its quarterly earnings results on Wednesday, May 29th. The company reported C$0.06 EPS for the quarter. Covalon Technologies had a negative return on equity of 13.22% and a negative net margin of 10.57%. The firm had revenue of C$8.41 million during the quarter.

Covalon Technologies Price Performance

Covalon Technologies stock opened at C$2.59 on Monday. The company has a debt-to-equity ratio of 6.34, a current ratio of 6.80 and a quick ratio of 6.45. Covalon Technologies has a one year low of C$0.96 and a one year high of C$2.61. The firm has a market capitalization of C$63.90 million, a P/E ratio of -21.58 and a beta of 0.66. The business has a fifty day moving average price of C$2.16 and a 200-day moving average price of C$1.59.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.